Cg Oncology, Inc. (CGON) SEC Filings — 2024

Filings

• CG Oncology Files S-1/A Amendment — S-1/A · Dec 11, 2024
• CG Oncology Files 8-K — 8-K · Dec 5, 2024
• CG Oncology Q3 10-Q: R&D Expenses and Stock Details — 10-Q · Nov 12, 2024
• Cg Oncology, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Cg Oncology, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
• Cg Oncology, Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• Cg Oncology, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
• CG Oncology Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Cg Oncology, Inc. SC 13G Filing — SC 13G · Jul 22, 2024
• CG Oncology Files 8-K — 8-K · May 24, 2024
• CG Oncology Files 8-K on Operations and Financials — 8-K · May 9, 2024
• CG Oncology, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• CG Oncology's Cretostim Gets EU Orphan Drug Status for Bladder Cancer — 8-K · May 3, 2024
• Cg Oncology, Inc. SC 13G/A Filing — SC 13G/A · Apr 9, 2024
• CG Oncology, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
• Cg Oncology, Inc. SC 13G Filing — SC 13G · Mar 14, 2024
• CG Oncology Reports Executive & Board Changes, Compensation Details — 8-K · Feb 16, 2024
• TCG Crossover GP I Discloses 10% Stake in CG Oncology — SC 13G · Feb 9, 2024
• Decheng Capital Takes 20% Stake in CG Oncology — SC 13G · Feb 8, 2024
• Longitude Capital Discloses 9.9% Stake in CG Oncology — SC 13G · Feb 5, 2024
• Foresite Capital Discloses Significant Stake in CG Oncology — SC 13G · Feb 5, 2024
• CG Oncology Confirms Nasdaq Listing for Common Stock (CGON) — 8-K · Jan 30, 2024
• CG Oncology, Inc. Files Amendment No. 2 to S-1 Registration Statement — S-1/A · Jan 23, 2024
• CG Oncology, Inc. Files Amendment to Registration Statement — S-1/A · Jan 18, 2024
• CG Oncology, Inc. Files S-1 Registration Statement — S-1 · Jan 2, 2024